Cara Therapeutics Inc. (NASDAQ: CARA) Stock Information | RedChip

Cara Therapeutics Inc. (NASDAQ: CARA)


$0.4160
-0.0066 ( +0.73% ) 10.6K

Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Market Data


Open


$0.4160

Previous close


$0.4226

Volume


10.6K

Market cap


$23.18M

Day range


$0.3970 - $0.4240

52 week range


$0.2257 - $1.1500

SEC Filings


Form Type Description Pages Date
8-k/a 8K-related 45 Dec 20, 2024
8-k 8K-related 53 Dec 18, 2024
8-k 8K-related 13 Nov 22, 2024
10-q Quarterly Reports 91 Nov 14, 2024
4 Insider transactions 1 Nov 06, 2024
10-q Quarterly Reports 91 Aug 14, 2024
4 Insider transactions 1 Aug 02, 2024
8-k 8K-related 13 Aug 01, 2024
8-k 8K-related 13 Jun 18, 2024
8-k 8K-related 15 Jun 12, 2024

Latest News